Pharmacy Jurisprudence Canada Exam
- Bill 25 - The Health Professions (Regulatory Reform) Amendment Act, 2008 -
ANSWER-formalizes a pharmacist's authority to 'renew existing prescriptions'
"final check" provincial regs - ANSWER-ensuring that: (a) the prescription product and
the prescription product label match the prescription information and the information on
the manufacturer's label with respect to: (i) drug, (ii) dosage form, (iii) strength, (iv)
quantity, and (v) drug identification number; (b) the prescription product label matches
the prescription information with respect to the matters set out in section 6(2)(a) to (g);
(c) the drug has not expired and will not expire within the duration of use; and (d) a
pharmacist has completed a clinical assessment of the prescription after reviewing the
patient profile.
"Protocol for Medication Management - Adapting a Prescription", approved by College
council in September 2007 - ANSWER-provides the framework to guide pharmacists in
the safe and effective adaptation, including renewal, of existing prescriptions. PPP-58 is
applicable to pharmacists in all practice settings, including community, long-term care,
hospital and other institutional pharmacy settings.
A community pharmacy may outsource prescription processing if - ANSWER-(a) all
locations involved in the outsourcing are community pharmacies, (b) all prescriptions
dispensed are labeled and include an identifiable code that provides a complete audit
trail for the dispensed drug, and (c) a notice is posted informing patients that the
preparation of their prescriptions may be outsourced to another pharmacy. (2) The
manager of an outsourcing community pharmacy must ensure that all applicable
standards of practice are met in processing prescriptions at all locations involved in the
outsourcing
A community pharmacy or telepharmacy must: - ANSWER-(a) keep Schedule IA drugs
in a locked metal safe inside the dispensary that is secured in place and equipped with
a time delay lock set at a minimum of five minutes; (b) install and maintain a security
camera system that: (i) has date/time stamp images that are archived and available for
no less than 30 days; and (ii) is checked daily for proper operation; and (c) install and
maintain motion sensors in the dispensary
A community pharmacy's manager must establish and maintain written quality
management policies and procedures that - ANSWER-(a) ensure pharmacy staff,
equipment, and facilities comply with all legislation, bylaws and policies applicable to the
operation of a community pharmacy, (b) include a process to monitor compliance with
the quality management policies and procedures, and (c) include a process for
reporting, documenting and following up on known, alleged and suspected errors,
incidents and discrepancies.
,A direct owner, directors and officers must do all of the following: - ANSWER-ensure
compliance with subsections (2)(c)(i), (c)(iii), (c)(iv), (c)(v), (i), (j), (l), (q), (r), (y) and (z);
(b) ensure that the requirements to hold a pharmacy licence under the Act are met at all
times; and (c) notify the registrar of any change of name, address, telephone number,
electronic mail address or any other information previously provided to the registrar; (8)
Shareholders must comply with subsections (2)(i) and (7)(c).
A drug listed in the Prescription Drug List under the Food and Drug Regulations that is a
prescription may be included under a different name or therapeutic classification in the
BC drug schedules - ANSWER-For example: estrogen and progesterone are included
under Sex Hormones; warfarin is included under 4-hydroxycoumarin; prednisone is
included under Adrenocortical Hormones
A full pharmacist may adjust the quantity of drug to be dispensed, if - ANSWER-(a) he
or she consults with a practitioner and documents the result of the consultation, and (b)
if (i) a poor compliance history is evident on the patient record, (ii) drug misuse is
suspected, or (iii) the safety of the patient is in question due to the potential for
overdose.
A full pharmacist must (provincial regs) - ANSWER-(a) review prescriptions for
completeness and appropriateness with respect to the drug, dosage, route and
frequency of administration, (b) review patient personal health information for drug
therapy problems, therapeutic duplications and any other potential problems, (c) consult
with patients concerning the patient's drug history and other personal health information,
(d) consult with practitioners with respect to a patient's drug therapy unless s.25.92(2) of
the Act applies, and (e) take appropriate action respecting a drug therapy problem
A full pharmacist must maintain a record of the reviews referred to in subsection (1) in
the resident's record and in the record at the pharmacy, and the record of review must
include information about - ANSWER-(a) the people in attendance, (b) the date of the
review, and (c) recommendations, if any.
A full pharmacist must review the resident record before dispensing a drug and take
appropriate action when necessary with respect to - ANSWER-(a) the appropriateness
of drug therapy, (b) drug interactions, (c) allergies, adverse drug reactions, and
intolerances, 5080-HPA_Bylaws_Residential_Care v2020.1 Effective 2020-06-19
(Posted 2020-06-19) College of Pharmacists of BC - Residential Care Facilities and
Homes Standards of Practice 11 (d) therapeutic duplication, (e) contraindicated drugs,
(f) the degree of compliance, (g) the correct dosage, route, frequency and duration of
administration and dosage form, and (h) any other potential drug-related problems.
A new prescription from a practitioner is required each time a drug is dispensed, except
for - ANSWER-(a) a part-fill, (b) a prescription authorizing repeats, (c) a full pharmacist-
initiated renewal or adaptation, or 5082-PODSA_Bylaws v2020.3 Effective 2020-05-07
(Posted 2020-05-07) College of Pharmacists of BC - PODSA Bylaws 21 (d) an
emergency supply for continuity of care. (8) Subsection (6) does not apply to
,prescriptions written for (a) residents of a facility or home subject to the requirements of
the Residential Care Facilities and Homes Standards of Practice, or (b) patients
admitted to a hospital.
A person may sell a prescription drug to (Federal regs) - ANSWER-(a) a drug
manufacturer;
(b) a practitioner;
(c) a wholesale druggist;
(d) a pharmacist; or
(e) the Government of Canada or the government of a province, for the use of a
department or agency of that government, on receipt of a written order signed by the
minister responsible for the department or by the person in charge of the agency, or by
their duly authorized representative.
A person may sell, possess or otherwise deal in a test kit if the following conditions are
met: - ANSWER-(a) a registration number has been issued for the test kit under section
G.01.008 and has not been cancelled under section G.01.009;
(b) the test kit bears, on its external surface,
(i) the name of the manufacturer,
(ii) the trade name or trademark, and
(iii) the registration number; and
(c) the test kit will be used for a medical, laboratory, industrial, educational, law
administration or enforcement, or research purpose.
A person who, under subsection C.01.048(1), receives an order for and distributes or
causes to be distributed a drug as a sample shall - ANSWER-(a) maintain records
showing
(i) the name, address and description of each person to whom the drug is distributed,
(ii) the brand name, quantity and form of the drug distributed, and
(iii) the date upon which each such distribution was made; and
(b) keep those records and all orders received for drugs in accordance with section
C.01.048 for a period of not less than two years from the date upon which the
distribution referred to in the records was made.
A pharmacist may only refill a prescription for a targeted substance if (Fed Regs) -
ANSWER-(a) the practitioner who prescribed it expressly directs that the prescription
may be refilled and specifies the number of refills;
(b) the pharmacist makes a record of each refill in accordance with section 53;
(c) less than one year has elapsed since the day on which the prescription was issued
by the practitioner;
(d) at least one refill remains on the prescription; and
(e) in the case where an interval between refills has been specified by the practitioner, it
has expired.
Marginal note:
, A pharmacist may sell, provide, send, deliver or transport a targeted substance without
a prescription to any of the following persons on receipt of an order from that person
that specifies the name and quantity of the targeted substance: (Fed Regs) - ANSWER-
(a) if the order is written, a licensed dealer who
(i) sold or provided the targeted substance, or
(ii) is licensed to destroy targeted substances, other than those that the licensed dealer
produced, made, assembled, sold or provided;
(b) subject to subsection (2),
(i) a practitioner,
(ii) another pharmacist, if the other pharmacist states that the targeted substance is
required because of a delay or shortfall in an order for the targeted substance placed
with a licensed dealer, or
(iii) a hospital, if the order is placed by a pharmacist practising in the hospital or by a
practitioner who is authorized to order the targeted substance on behalf of the hospital;
(c) the Minister, if the order is a written order signed on the Minister's behalf; or
(d) a person to whom an exemption with respect to the targeted substance has been
granted under section 56 of the Act, if the order is a written order and is accompanied
by a copy of the exemption.
A pharmacist must, before dispensing a controlled drug in accordance with a verbal
order or prescription, make a written record of it that sets out (Federal regs) - ANSWER-
a) their name or initials;
(b) the name, initials and municipal address of the practitioner who issued the order or
prescription;
(c) the name and municipal address of the person named in the order or prescription;
(d) the name, form and quantity of the controlled drug;
(e) the directions for use given with the order or prescription;
(f) the date on which the controlled drug was dispensed; and
(g) the number assigned to the order or prescription.
A pharmacist shall not refill a prescription for a controlled drug unless - ANSWER-(a)
the practitioner, at the time that he issued the prescription, directed in writing, in the
case of a controlled drug listed in Part I of the schedule to this Part, or directed in writing
or orally, in the case of a controlled drug listed in Part II or III of the schedule to this
Part, that the prescription be refilled, the number of times that it may be refilled and the
dates for or the intervals between refills; and
(b) the pharmacist keeps a record of each refilling of a prescription.
A pharmacist shall provide information and assist an inspector by - ANSWER-(a) furnish
such information respecting the dealings of the pharmacist in any controlled drug in
such form and at such times as the Minister may require;
(b) make available and produce to an inspector upon request his special prescription file
together with any books, records or documents which he is required to keep;
(c) permit an inspector to make copies of or to take extracts from such files, books,
records or documents; and
(d) permit an inspector to check all stocks of controlled drugs on his premises.
- Bill 25 - The Health Professions (Regulatory Reform) Amendment Act, 2008 -
ANSWER-formalizes a pharmacist's authority to 'renew existing prescriptions'
"final check" provincial regs - ANSWER-ensuring that: (a) the prescription product and
the prescription product label match the prescription information and the information on
the manufacturer's label with respect to: (i) drug, (ii) dosage form, (iii) strength, (iv)
quantity, and (v) drug identification number; (b) the prescription product label matches
the prescription information with respect to the matters set out in section 6(2)(a) to (g);
(c) the drug has not expired and will not expire within the duration of use; and (d) a
pharmacist has completed a clinical assessment of the prescription after reviewing the
patient profile.
"Protocol for Medication Management - Adapting a Prescription", approved by College
council in September 2007 - ANSWER-provides the framework to guide pharmacists in
the safe and effective adaptation, including renewal, of existing prescriptions. PPP-58 is
applicable to pharmacists in all practice settings, including community, long-term care,
hospital and other institutional pharmacy settings.
A community pharmacy may outsource prescription processing if - ANSWER-(a) all
locations involved in the outsourcing are community pharmacies, (b) all prescriptions
dispensed are labeled and include an identifiable code that provides a complete audit
trail for the dispensed drug, and (c) a notice is posted informing patients that the
preparation of their prescriptions may be outsourced to another pharmacy. (2) The
manager of an outsourcing community pharmacy must ensure that all applicable
standards of practice are met in processing prescriptions at all locations involved in the
outsourcing
A community pharmacy or telepharmacy must: - ANSWER-(a) keep Schedule IA drugs
in a locked metal safe inside the dispensary that is secured in place and equipped with
a time delay lock set at a minimum of five minutes; (b) install and maintain a security
camera system that: (i) has date/time stamp images that are archived and available for
no less than 30 days; and (ii) is checked daily for proper operation; and (c) install and
maintain motion sensors in the dispensary
A community pharmacy's manager must establish and maintain written quality
management policies and procedures that - ANSWER-(a) ensure pharmacy staff,
equipment, and facilities comply with all legislation, bylaws and policies applicable to the
operation of a community pharmacy, (b) include a process to monitor compliance with
the quality management policies and procedures, and (c) include a process for
reporting, documenting and following up on known, alleged and suspected errors,
incidents and discrepancies.
,A direct owner, directors and officers must do all of the following: - ANSWER-ensure
compliance with subsections (2)(c)(i), (c)(iii), (c)(iv), (c)(v), (i), (j), (l), (q), (r), (y) and (z);
(b) ensure that the requirements to hold a pharmacy licence under the Act are met at all
times; and (c) notify the registrar of any change of name, address, telephone number,
electronic mail address or any other information previously provided to the registrar; (8)
Shareholders must comply with subsections (2)(i) and (7)(c).
A drug listed in the Prescription Drug List under the Food and Drug Regulations that is a
prescription may be included under a different name or therapeutic classification in the
BC drug schedules - ANSWER-For example: estrogen and progesterone are included
under Sex Hormones; warfarin is included under 4-hydroxycoumarin; prednisone is
included under Adrenocortical Hormones
A full pharmacist may adjust the quantity of drug to be dispensed, if - ANSWER-(a) he
or she consults with a practitioner and documents the result of the consultation, and (b)
if (i) a poor compliance history is evident on the patient record, (ii) drug misuse is
suspected, or (iii) the safety of the patient is in question due to the potential for
overdose.
A full pharmacist must (provincial regs) - ANSWER-(a) review prescriptions for
completeness and appropriateness with respect to the drug, dosage, route and
frequency of administration, (b) review patient personal health information for drug
therapy problems, therapeutic duplications and any other potential problems, (c) consult
with patients concerning the patient's drug history and other personal health information,
(d) consult with practitioners with respect to a patient's drug therapy unless s.25.92(2) of
the Act applies, and (e) take appropriate action respecting a drug therapy problem
A full pharmacist must maintain a record of the reviews referred to in subsection (1) in
the resident's record and in the record at the pharmacy, and the record of review must
include information about - ANSWER-(a) the people in attendance, (b) the date of the
review, and (c) recommendations, if any.
A full pharmacist must review the resident record before dispensing a drug and take
appropriate action when necessary with respect to - ANSWER-(a) the appropriateness
of drug therapy, (b) drug interactions, (c) allergies, adverse drug reactions, and
intolerances, 5080-HPA_Bylaws_Residential_Care v2020.1 Effective 2020-06-19
(Posted 2020-06-19) College of Pharmacists of BC - Residential Care Facilities and
Homes Standards of Practice 11 (d) therapeutic duplication, (e) contraindicated drugs,
(f) the degree of compliance, (g) the correct dosage, route, frequency and duration of
administration and dosage form, and (h) any other potential drug-related problems.
A new prescription from a practitioner is required each time a drug is dispensed, except
for - ANSWER-(a) a part-fill, (b) a prescription authorizing repeats, (c) a full pharmacist-
initiated renewal or adaptation, or 5082-PODSA_Bylaws v2020.3 Effective 2020-05-07
(Posted 2020-05-07) College of Pharmacists of BC - PODSA Bylaws 21 (d) an
emergency supply for continuity of care. (8) Subsection (6) does not apply to
,prescriptions written for (a) residents of a facility or home subject to the requirements of
the Residential Care Facilities and Homes Standards of Practice, or (b) patients
admitted to a hospital.
A person may sell a prescription drug to (Federal regs) - ANSWER-(a) a drug
manufacturer;
(b) a practitioner;
(c) a wholesale druggist;
(d) a pharmacist; or
(e) the Government of Canada or the government of a province, for the use of a
department or agency of that government, on receipt of a written order signed by the
minister responsible for the department or by the person in charge of the agency, or by
their duly authorized representative.
A person may sell, possess or otherwise deal in a test kit if the following conditions are
met: - ANSWER-(a) a registration number has been issued for the test kit under section
G.01.008 and has not been cancelled under section G.01.009;
(b) the test kit bears, on its external surface,
(i) the name of the manufacturer,
(ii) the trade name or trademark, and
(iii) the registration number; and
(c) the test kit will be used for a medical, laboratory, industrial, educational, law
administration or enforcement, or research purpose.
A person who, under subsection C.01.048(1), receives an order for and distributes or
causes to be distributed a drug as a sample shall - ANSWER-(a) maintain records
showing
(i) the name, address and description of each person to whom the drug is distributed,
(ii) the brand name, quantity and form of the drug distributed, and
(iii) the date upon which each such distribution was made; and
(b) keep those records and all orders received for drugs in accordance with section
C.01.048 for a period of not less than two years from the date upon which the
distribution referred to in the records was made.
A pharmacist may only refill a prescription for a targeted substance if (Fed Regs) -
ANSWER-(a) the practitioner who prescribed it expressly directs that the prescription
may be refilled and specifies the number of refills;
(b) the pharmacist makes a record of each refill in accordance with section 53;
(c) less than one year has elapsed since the day on which the prescription was issued
by the practitioner;
(d) at least one refill remains on the prescription; and
(e) in the case where an interval between refills has been specified by the practitioner, it
has expired.
Marginal note:
, A pharmacist may sell, provide, send, deliver or transport a targeted substance without
a prescription to any of the following persons on receipt of an order from that person
that specifies the name and quantity of the targeted substance: (Fed Regs) - ANSWER-
(a) if the order is written, a licensed dealer who
(i) sold or provided the targeted substance, or
(ii) is licensed to destroy targeted substances, other than those that the licensed dealer
produced, made, assembled, sold or provided;
(b) subject to subsection (2),
(i) a practitioner,
(ii) another pharmacist, if the other pharmacist states that the targeted substance is
required because of a delay or shortfall in an order for the targeted substance placed
with a licensed dealer, or
(iii) a hospital, if the order is placed by a pharmacist practising in the hospital or by a
practitioner who is authorized to order the targeted substance on behalf of the hospital;
(c) the Minister, if the order is a written order signed on the Minister's behalf; or
(d) a person to whom an exemption with respect to the targeted substance has been
granted under section 56 of the Act, if the order is a written order and is accompanied
by a copy of the exemption.
A pharmacist must, before dispensing a controlled drug in accordance with a verbal
order or prescription, make a written record of it that sets out (Federal regs) - ANSWER-
a) their name or initials;
(b) the name, initials and municipal address of the practitioner who issued the order or
prescription;
(c) the name and municipal address of the person named in the order or prescription;
(d) the name, form and quantity of the controlled drug;
(e) the directions for use given with the order or prescription;
(f) the date on which the controlled drug was dispensed; and
(g) the number assigned to the order or prescription.
A pharmacist shall not refill a prescription for a controlled drug unless - ANSWER-(a)
the practitioner, at the time that he issued the prescription, directed in writing, in the
case of a controlled drug listed in Part I of the schedule to this Part, or directed in writing
or orally, in the case of a controlled drug listed in Part II or III of the schedule to this
Part, that the prescription be refilled, the number of times that it may be refilled and the
dates for or the intervals between refills; and
(b) the pharmacist keeps a record of each refilling of a prescription.
A pharmacist shall provide information and assist an inspector by - ANSWER-(a) furnish
such information respecting the dealings of the pharmacist in any controlled drug in
such form and at such times as the Minister may require;
(b) make available and produce to an inspector upon request his special prescription file
together with any books, records or documents which he is required to keep;
(c) permit an inspector to make copies of or to take extracts from such files, books,
records or documents; and
(d) permit an inspector to check all stocks of controlled drugs on his premises.
